Direct-to-Consumer Drug Advertising Faces Renewed Scrutiny as Spending Tops $9 Billion
Total spending on direct-to-consumer prescription drug advertising reached $9 billion in 2024, prompting renewed debate over whether such marketing should be legal. The U.S. and New Zealand remain the only developed nations allowing the practice.